Gottesfeld J M, Turner J M, Dervan P B
Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Gene Expr. 2000;9(1-2):77-91. doi: 10.3727/000000001783992696.
A current goal in molecular medicine is the development of new strategies to interfere with gene expression in living cells in the hope that novel therapies for human disease will result from these efforts. This review focuses on small-molecule or chemical approaches to manipulate gene expression by modulating either transcription of messenger RNA-coding genes or protein translation. The molecules under study include natural products, designed ligands, and compounds identified through functional screens of combinatorial libraries. The cellular targets for these molecules include DNA, messenger RNA, and the protein components of the transcription, RNA processing, and translational machinery. Studies with model systems have shown promise in the inhibition of both cellular and viral gene transcription and mRNA utilization. Moreover, strategies for both repression and activation of gene transcription have been described. These studies offer promise for treatment of diseases of pathogenic (viral, bacterial, etc.) and cellular origin (cancer, genetic diseases, etc.).
分子医学当前的一个目标是开发新策略,以干扰活细胞中的基因表达,期望这些努力能带来针对人类疾病的新疗法。本综述聚焦于通过调节信使RNA编码基因的转录或蛋白质翻译来操纵基因表达的小分子或化学方法。所研究的分子包括天然产物、设计的配体以及通过组合文库功能筛选鉴定出的化合物。这些分子的细胞靶点包括DNA、信使RNA以及转录、RNA加工和翻译机制的蛋白质成分。对模型系统的研究已显示出在抑制细胞和病毒基因转录以及mRNA利用方面的前景。此外,还描述了基因转录抑制和激活的策略。这些研究为治疗病原性(病毒、细菌等)和细胞源性(癌症、遗传疾病等)疾病带来了希望。